Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT07168798
Enrolling by invitation Observational

SpO2 Accuracy in Children

NCT07168798 · tracked via the Priya Life Science USA tracker
Sponsor
Nihon Kohden
Phase
Observational
Started
2025-11-12
Last updated
2025-11-21

Condition(s) studied

Hypoxemia

Investigational drug(s) / intervention(s)

Pulse oximeter

Pulse oximeter: OLV-4201 pulse oximeter with sensors: TL-272T3, TL-274T3 and TL-273T3

Study summary

Evaluation of SpO2 Accuracy in Children with Various Skin Color

Eligibility

Sex
ALL
Min age
0 Days
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 0 - 12 who are admitted to the CICU with or plan to have an indwelling arterial line for standard care Exclusion Criteria: * Patients with elevated levels of methemoglobin and carboxyhemoglobin, or anemia. * Patients with prolonged hypotension at the time of enrollment. * Patients with ductal-dependent congenital cardiac disease.

Primary outcome measure(s)

  • SpO2 accuracy — 24 hours
    Evaluate the accuracy of Nihon Kohden SpO2 in measuring blood oxygen levels in children with varying skin tones

Trial sites (1)

FacilityCityRegionStatus
Childrens Hospital of Philadelphia Philadelphia Pennsylvania

More Nihon Kohden trials in the USA

Hypoxia and Hemodilution Testing in Healthy Adult Volunteers Starting soon
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements Active, not recruiting
Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031) Active, not recruiting
Pulse Oximeter Accuracy During Stable Hypoxia Plateaus Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07168798 on ClinicalTrials.gov ↗ ← All trials in the USA